Search results
Corticosteroids (Systemic): Risk of Pheochromocytoma Crisis. Direktif untuk semua produk yang mengandungi chloroquine dan hydroxychloroquine: Pengemaskinian sisip bungkusan dan Risalah Maklumat Ubat untuk Pengguna (RiMUP) bagi memperkukuhkan maklumat keselamatan berkaitan risiko psychiatric disorders.
Nov 14, 2018 · LATAR BELAKANG NPRA. Bahagian Regulatori Farmasi Negara (NPRA), atau dikenali sebagai Biro Pengawalan Farmaseutikal Kebangsaan (BPFK), telah ditubuhkan pada Oktober 1978 dibawah aktiviti kawalan kualiti program farmasi dan bekalan.
QUEST 3+ Online Submission System enabled Product License Holder, Manufacturer, Importer, Re-packer, Reseller and other related users to conduct secured online transactions for product registration, variation, licensing, market sampling, renewal and other transactions.
INTRODUCTION. This “ DRUG REGISTRATION GUIDANCE DOCUMENT (DRGD)” will serve as the reference guide for the registration process including quality control, inspection & licensing and post-registration activities of medicinal products.
Biro Pengawalan Farmaseutikal Kebangsaan (BPFK) yang dahulunya dikenali sebagai Makmal Kimia Ubat Kebangsaan ditubuhkan di bawah aktiviti Kawalan Kualiti Program Farmasi dan Bekalan. Institusi ini ditubuhkan untuk menjalankan ujian Kawalan Kualiti produk farmaseutikal. Apabila Peraturan Kawalan Dadah dan Kosmetik (Control of Drugs and Cosmetics Regulations) 1984 digubal dan Pihak Berkuasa ...
Thrombocytopenia and coagulation disorders A very rare and serious combination of thrombosis and thrombocytopenia, including thrombosis with thrombocytopenia syndrome (TTS), in some cases accompanied by bleeding, has been observed following vaccination with Vaxzevria during post-authorisation use. This includes cases presenting as venous thrombosis, including unusual sites such as cerebral ...
Apr 11, 2022 · The following cosmetic manufacturers comply to GMP requirements according to the ASEAN Guidelines for Cosmetic Good Manufacturing Practice. The list below is limited to manufacturers who manufacture cosmetics only (i.e. excludes licensed manufacturers with cosmetic manufacturing facility).
The National Pharmaceutical Control Bureau (Biro Pengawalan Farmaseutikal Kebangsaan - BPFK) shall not be liable for any loss or damage caused by the usage of any information obtained from this website. Companies referred to in this web site shall not be construed as agents nor as companies recommended by BPFK of Malaysia.
Pendaftaran Produk, Sistem QUEST3+, Garis Panduan, Borang Permohonan, FAQs. National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health Malaysia. Malaysia Drug Control Authority.
QUEST 3+ shall not be responsible or liable for the accuracy, usefulness or availability of any information transmitted via the Service, and shall not be responsible or liable for any trading or investment decisions made based on such information. 19. NOTICE Notices to you may be made via either email or regular mail.
